John Dobak, M.D.
John Dobak, M.D., is the Chairman of 10xBio. He has spent the last 25 years developing novel medical technologies. Most recently he served as the CEO of DermTech, the leader in genomics and precision medicine for dermatology. Dr. Dobak has founded numerous companies and led them through development to product launch and successful exits.
Dan Piacquadio, M.D.
Dan Piacquadio, M.D., is a board member and leads the clinical and regulatory development for 10xBio. Dan has over 20 years experience in developing new medical therapies and currently serves as the CEO of Therapeutics, Inc.
Get the most recent updates about 10xBio.
Recent Press Releases
10xBio Announces the Completion of Enrollment In Phase 2b Clinical Trial of Novel Drug For Submental Body Contouring
10xBio, LLC, a biotechnology company that focuses on new uses for existing therapies and technologies, announced today that it has completed enrollment in a repeat treatment study of its novel injectable drug for submental body contouring.
SAN DIEGO (July 15, 2023) – 10xBio, LLC, a privately-held biotechnology company, announces that in the past 24 months it has been issued 3 patents from the U.S. Patent…
SAN DIEGO (August 23, 2021) – 10xBio, LLC, a privately-held biotechnology company, completed a Series B financing from a select group of partners and private investors.
Thank you for your interest in 10xBio. Complete the form below and we will get back to you soon.